Intraoperative Neuromonitoring Market

Intraoperative Neuromonitoring (IONM) Market by Product & Services (Systems, Services, Accessories), by Source Type (Insourced, Outsourced), by Application (Spinal, Neurosurgery, Orthopedic, ENT, Vascular), by Modality (EMG, EEG, MEPs, SSEPs, VEPs, BAEPs), by End User (Hospitals, ASCs), by Geography (U.S., Canada, Mexico, Germany, France, U.K., Italy, Spain, Japan, China, Australia, India, South Korea, Brazil, South Africa, Saudi Arabia) – Global Market Size, Share, Development, Growth, and Demand Forecast, 2016-2023

Published: February 2017
Report Code: LS11383
Available Format:
Pages: 105

Intraoperative Neuromonitoring Market Overview

The global intraoperative neuromonitoring (IONM) market size is estimated to be valued at more than $3 billion in 2016, and it is forecasted to grow at a CAGR of around 7% during 2017–2023. In terms of both size and growth, the services market is expected to witness the fastest CAGR of around 10% during the forecast period.





By source type, the insourced monitoring segment is the higher contributor to the global intraoperative neuromonitoring market, however, outsourced monitoring is anticipated to witness the faster growth in demand at a CAGR of around 13.0% during the forecast period. Adoption of outsourced monitoring among hospitals and ASCs, along with the benefits of outsourced monitoring over insourced monitoring are factors driving the growth of the outsourced monitoring category during the forecast period.

Intraoperative neuromonitoring employs a wide variety of modalities, which include somatosensory evoked potentials (SSEPs), motor evoked potentials (MEPs), electromyography (EMG), electroencephalography (EEG), visual evoked potentials (VEPs), and brainstem auditory evoked potentials (BAEPs). EMG segment was the highest contributor to the global market with more than $900 million revenue in 2016.

Spinal surgery is an application of intraoperative neuromonitoring, with the largest contribution in revenue generation due to the increasing prevalence of spinal injuries, for instance, according to the WHO estimates, in 2014, over 1.9 billion adults in the age group 18 years and above were overweight. Of these, ~600 million adults were obese. Therefore, obesity can lead to the development of other spinal disorders, which in turn increases the number of treatment surgeries and ultimately leads to increase in the number of spinal intraoperative neuromonitoring procedures.

By end user, the hospitals held the largest share in the intraoperative neuromonitoring market in 2016, globally. However, Ambulatory surgery centers (ASCs) are estimated to witness the faster growth in demand, registering a CAGR of around 7% during the forecast period. The preference of ASCs is majorly due to the availability of cost- effective, high-quality alternative to hospital-based treatment, and outsourcing of services by key players to ASCs are factors for its faster growth during the forecast period.

Globally, North America is the largest contributor to the global intraoperative neuromonitoring market, with more than 40% contribution in 2016. The leading position of the region is attributed to the presence of a large number of hospitals and increasing number of surgeries in the region. Moreover, awareness among people about intraoperative neuromonitoring will also drive the North American market.

Intraoperative Neuromonitoring Market Dynamics

Growth Drivers

Factors driving the growth of the intraoperative neuromonitoring market are the rising geriatric population, increasing prevalence of chronic disorders, applications of IONM in various surgeries, and risk management through intraoperative neuromonitoring during complex surgeries.

One of the major chronic diseases prevalent globally, is cardiac diseases, and according to the 2013 statistics of American Heart Association, 5.7 million people were affected by heart failure in the U.S. alone, while 10 million in European countries. Furthermore, in the U.S., around 700,000 new cases of heart failure are diagnosed annually and approximately 58,000 patient deaths are attributed to heart failure annually. As IONM is an important aspect of vascular surgeries, the increase in prevalence of cardiac disorders would lead to increase in the number of vascular surgeries, which in turn would drive the intraoperative neuromonitoring market.

IONM is an important procedure that helps in risk management during complex surgical procedures. The use of IONM during a surgical procedure helps in the reduction of impairment risks to neurophysiologically relevant nerve structures; or possible impairment of nerve function as a result of improper positioning of the patient. With the help of IONM modalities, nerve structures can be identified and potential impairment can be prevented. Thus, IONM enables surgeons to focus on optimizing the intervention without causing any harm to the neural structures, which is expected to drive the growth of the intraoperative neuromonitoring market.


Increasing trend of medical tourism, and the growth opportunities in emerging economies are expected to provide ample opportunities to the players operating in the intraoperative neuromonitoring market. Increasing medical tourism is a major opportunity for the intraoperative neuromonitoring market as spine surgery is one of the fastest growing specialties in medical tourism. Use of IONM through medical tourism would lead to improvement of surgical outcomes across the globe.

Intraoperative Neuromonitoring Market Competitive Landscape

As part of the business strategy, major market players are focusing on undergoing acquisitions of other players as part of their business strategy to increase their intraoperative neuromonitoring market share in the coming years. For instance, in June 2016, NuVasive, Inc. acquired Biotronic NeuroNetwork, a provider of IONM services, for $98 million in cash. The acquisition was made to enhance NuVasive’s spine service line partnership offerings.

Similarly, in March 2016, Natus Medical Incorporated acquired the assets of NeuroQuest, LLC, a U.S.-based provider of neurodiagnostic services. This acquisition enabled the company to expand its neurodiagnostic services across seven new states of the U.S.

Some of the other major players of the intraoperative neuromonitoring industry are Accurate Monitoring LLC, Computational Diagnostics, Inc., IntraNerve, LLC, Inomed Medizintechnik GmbH, Medtronic plc, Moberg Research, Inc., Nihon Kohden Corporation, and SpecialtyCare.

Place An Order

Single User License

The report will be delivered in PDF format without printing rights. It is recommended for a single user.

USD 5100
Group License

The report will be delivered in PDF format along with the printing rights. It is recommended for up to five users.

USD 6100
Enterprise License

The report will be delivered in PDF format along with printing rights and detailed Excel sheet. It is recommended for organizations where multiple people would like to access the report from multiple locations.

USD 9100

Pre-Purchase Enquiry